Literature DB >> 8419401

Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF receptors.

M Rusnati1, C Urbinati, M Presta.   

Abstract

We have shown (Presta et al., Cell Regul., 2:719-726, 1991) that a long-lasting interaction of basic fibroblast growth factor (bFGF) with endothelial GM 7373 cells is required to induce cell proliferation. In the present work, we have investigated the interaction of 125I-bFGF with GM 7373 cells, its pathway of internalization, and its intracellular fate under the same experimental conditions previously utilized to assess the mitogenic activity of the growth factor. Cell cultures were incubated with 10 ng/ml 125I-bFGF for 2 h at 4 degrees C. Then, cells were shifted to 37 degrees C without changing the medium. A rapid down-regulation of high affinity sites, paralleled by a rapid internalization of 125I-bFGF, was observed during the first 1-2 h at 37 degrees C. After 6-8 h, also low affinity sites down-regulate. This was paralleled by a continuous internalization of 125I-bFGF and by a slow disappearance of the growth factor from the culture medium. This suggests that GM 7373 cells activate, when exposed to bFGF for a long period of time, a late internalization pathway mediated by low affinity sites. This hypothesis was supported by the following experimental evidence: 1) soluble heparin inhibited the prolonged internalization of 125I-bFGF and its binding to low affinity sites with the same potency; 2) treatment of GM 7373 cells with heparinase, which removes most of the low affinity sites, also inhibited the prolonged internalization of 125I-bFGF. 125I-bFGF internalized via low affinity sites was partially protected from lysosomal degradation. This was the case also when 125I-bFGF was internalized in the presence of soluble heparin, suggesting that the complexes bFGF-cell surface glycosaminoglycan and bFGF-soluble heparin are maintained during the internalization of the growth factor. Moreover, the capacity of soluble heparin to inhibit the mitogenic activity of bFGF also when added to cell cultures several hours after the growth factor indicates that the requirement for a prolonged interaction of bFGF with GM 7373 cells in order to induce cell proliferation might be related to the late internalization of the growth factor via low affinity sites.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8419401     DOI: 10.1002/jcp.1041540119

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  19 in total

1.  Microfluidic analysis of extracellular matrix-bFGF crosstalk on primary human myoblast chemoproliferation, chemokinesis, and chemotaxis.

Authors:  Meghaan M Ferreira; Ruby E Dewi; Sarah C Heilshorn
Journal:  Integr Biol (Camb)       Date:  2015-04-24       Impact factor: 2.192

2.  Heparin inhibits the binding of basic fibroblast growth factor to cultured human aortic smooth-muscle cells.

Authors:  F Bono; P Rigon; I Lamarche; P Savi; V Salel; J M Herbert
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

3.  Membrane-Type 1 Matrix Metalloproteinase Downregulates Fibroblast Growth Factor-2 Binding to the Cell Surface and Intracellular Signaling.

Authors:  Evelyne Tassone; Cristina Valacca; Paolo Mignatti
Journal:  J Cell Physiol       Date:  2015-02       Impact factor: 6.384

4.  Interaction of heparin with synthetic peptides corresponding to the C-terminal domain of intestinal mucins.

Authors:  G Xu; G G Forstner; J F Forstner
Journal:  Glycoconj J       Date:  1996-02       Impact factor: 2.916

5.  Blood-brain barrier transport of 125I-labeled basic fibroblast growth factor.

Authors:  Y Deguchi; T Naito; T Yuge; A Furukawa; S Yamada; W M Pardridge; R Kimura
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

6.  A distinct basic fibroblast growth factor (FGF-2)/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells.

Authors:  M Rusnati; P Dell'Era; C Urbinati; E Tanghetti; M L Massardi; Y Nagamine; E Monti; M Presta
Journal:  Mol Biol Cell       Date:  1996-03       Impact factor: 4.138

7.  Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins.

Authors:  Antonella Bugatti; Chiara Urbinati; Cosetta Ravelli; Erik De Clercq; Sandra Liekens; Marco Rusnati
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

8.  Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures.

Authors:  M Rusnati; E Tanghetti; C Urbinati; G Tulipano; S Marchesini; M Ziche; M Presta
Journal:  Mol Biol Cell       Date:  1999-02       Impact factor: 4.138

9.  Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor.

Authors:  D Coltrini; M Rusnati; G Zoppetti; P Oreste; G Grazioli; A Naggi; M Presta
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

Review 10.  Mechanisms of FGF gradient formation during embryogenesis.

Authors:  Revathi Balasubramanian; Xin Zhang
Journal:  Semin Cell Dev Biol       Date:  2015-10-08       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.